Risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus and hepatitis B vaccination status in Yunnan province, China

Vaccine

Volumn 32, Issue 27, 2014, Pages 3362-3366

  Kang, Wenyu ^a   Ding, Zhengrong ^a   Shen, Liping ^b   Zhao, Zhixian ^a   Huang, Guofei ^a   Zhang, Jie ^a   Xiong, Qing ^a   Zhang, Shuang ^b   Zhang, Shuo ^b   Wang, Feng ^b  

^a YUNNAN PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Hepatitis B virus; Immunoprophylaxis; Mother to child transmission; Risk factor

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; VIRUS DNA; HEPATITIS B HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN;

ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CHINA; DRUG TREATMENT FAILURE; EDUCATIONAL STATUS; FEMALE; GESTATIONAL AGE; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; INFECTION RISK; NEWBORN; POST EXPOSURE PROPHYLAXIS; POSTMATURITY; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; RURAL AREA; URBAN AREA; VACCINATION; VIRUS TRANSMISSION; BLOOD; CLINICAL TRIAL; EPIDEMIOLOGY; MULTICENTER STUDY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; VERTICAL TRANSMISSION;

CHINA; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNOGLOBULINS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS;

EID: 84901004917     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.045     Document Type: Article

References (20)

1. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988, 61(10):1942-1956.
2. Dai Z.C., Qi G.M. Viral Hepatitis in China sero-epidemiological survey in Chinese population (part one) 1995, 39-58. Science and Technology Document Press, Beijing.
3. Xia G.L., Liu C.B., Cao H.L., Bi S.L., Zhan M.Y., Su C.A., et al. Prevalence of hepatitis Band C virus infections in the general Chinese population. Results from a nationwide cross-sectional sero-epidemiologic study of hepatitis A, B, C, D and E virus infections in China, 1992. Int Hepatol Commun 1996, 5(1):62-73.
4. Lok A.S. Prevention of hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 2004, 127(5 Suppl. 1):S303-S309.
5. Liang X.F., Bi S.L., Yang W.Z., Wang L.D., Cui G., Cui F.Q. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009, 200(1):39-47.
6. Liang X.F., Bi S.L., Yang W.Z., Wang L.D., Cui G., Cui F.Q. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27(47):6550-6557.
7. The Guideline of Prevention and Treatment for Chronic Hepatitis B (2010 version). Chinese Medical Association; 2010.
8. Singh A.E., Plitt S.S., Osiowy C., Surynicz K., Kouadjo E., Preiksaitis J. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat 2011, 18(7):468-473.
9. Burk R.D., Hwang L.Y., Ho G.Y., Shafritz D.A., Beasley R.P. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994, 170(6):1418-1423.
10. Wang Z., Zhang J., Yang H., Li X., Wen S., Guo Y. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 2003, 71(3):360-366.
11. del Canho R., Grosheide P.M., Mazel J.A., Heijtink R.A., Hop W.C., Gerards L.J. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997, 15(15):1624-1630.
12. del Canho R., Grosheide P.M., Schalm S.W., de Vries R.R., Heijtink R.A. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol 1994, 20(4):483-486.
13. Lu L., Ding Z.R., Kong Y., Pang Y.K., Zhang J., Luo M. Serological epidemiology analysis of the hepatitis B virus infection in Yunnan Province. Chin Vaccine Immunol 2011, 17(1):33-36.
14. WHO Publication Hepatitis B vaccines: WHO position paper - recommendations. Vaccine 2010, 28(3):589-590.
15. Xu D.Z., Yan Y.P., Choi B.C., Xu J.Q., Men K., Zhang J.X. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002, 67(1):20-26.
16. Terrault N.A., Jacobson I.M. Treating chronic hepatitis B infection in patients who are pregnant or are undergoing immunosuppressive chemotherapy. Semin Liver Dis 2007, 27(Suppl. 1):18-24.
17. Mast E.E., Margolis H.S., Fiore A.E., Brink E.W., Goldstein S.T., Wang S.A. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR 2005, 54(RR-16):1-31.
18. Wang J.S., Zhu Q.R., Wang X.H. Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. Int J Clin Pract 2003, 57(2):100-102.
19. Chen X., Chen J., Wen J., Xu C., Zhang S., Zhou Y.H. Breastfeeding is not a risk factor for mother-to-child transmission of hepatitis B virus. PLoS ONE 2013, 8(1):e55303.
20. Song Y.M., Sung J., Yang S., Choe Y.H., Chang Y.S., Park W.S. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007, 166(8):813-818.